Article
Reduced plasma APJ levels and APLNR G212A polymorphism in Syrian patients with coronary artery disease.
Current medical research and opinion - 1 Mar 2026
Abd-Alkareem Maisaa Hassan, Mohammed Shibli Hussam Eddin, Alquobaili Faizeh Ali
Abstract excerpt
BACKGROUND: Coronary artery disease (CAD) remains a leading global cause of mortality. The apelin/apelin receptor (APJ) system has emerged as a novel pathway implicated in cardiovascular regulation and disease progression. This pioneering case-control study, the first conducted in a Syrian population, investigated the association of the apelin receptor G212A polymorphism and plasma APJ levels with CAD...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
